Related Experiment Video

Updated: Aug 26, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Contrast nephropathy after coronary angiography

Apoor S Gami1, Vesna D Garovic

  • 1Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA.

Mayo Clinic Proceedings
|February 13, 2004
PubMed

Insights

Contrast-induced nephropathy (CIN) after coronary angiography poses significant risks. Understanding risk factors and employing proven preventive strategies are crucial for patient care and reducing morbidity and mortality.

Area of Science:

  • Nephrology
  • Cardiology
  • Radiology

Background:

  • Contrast nephropathy (CN) is a serious complication following coronary angiography.
  • It is linked to substantial patient morbidity and mortality.
  • Understanding the pathophysiology and risk factors is essential for prevention.

Purpose of the Study:

  • To review the incidence, definition, and pathological mechanisms of contrast nephropathy.
  • To provide an overview of identified risk factors for contrast nephropathy.
  • To highlight effective preventive interventions and discuss those lacking benefit.

Main Methods:

  • Literature review and synthesis of existing research on contrast nephropathy.
  • Analysis of risk factors, diagnostic criteria, and pathological pathways.
  • Evaluation of the efficacy of various preventive strategies.

Main Results:

  • Contrast nephropathy is a recognized complication with significant adverse outcomes.
  • Several risk factors contribute to its development.
  • Specific interventions have been proven effective in preventing contrast nephropathy.

Conclusions:

  • Prevention of contrast nephropathy is paramount in patients undergoing coronary angiography.
  • Effective management relies on a thorough understanding of risk factors.
  • Implementing proven preventive strategies can mitigate the incidence and impact of contrast nephropathy.

More Related Videos

Coronary Angiography During Ex-Situ Heart Perfusion in a Porcine Model06:25

Coronary Angiography During Ex-Situ Heart Perfusion in a Porcine Model

Published on: July 12, 2024

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography05:14

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography

Published on: August 11, 2023

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...